Great Debate: Triple antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting should be limited to 1 week

Jiesuck Park, Jin‐Hyung Jung, Eue-Keun Choi, Seung‐Woo Lee, Soonil Kwon, So-Ryoung Lee, Jeehoon Kang, Kyungdo Han, Kyung Woo Park, Seil Oh, Professor Gregory Lip

Article2019

Management of Antithrombotic Therapy in Atrial Fibrillation Patients Undergoing PCI

Davide Capodanno, Kurt Huber, Roxana Mehran, Professor Gregory Lip, David P. Faxon, Christopher B. Granger, Pascal Vranckx, Renato D. Lópes, Gilles Montalescot, Christopher P. Cannon, Jurien Ten Berg, Bernard J. Gersh, Deepak L. Bhatt, Dominick J. Angiolillo

Great Debate: Triple antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting should be limited to 1 week

Abstract

Discussion(0)

Related publications

Management of antithrombotic therapy in AF patients presenting with ACS and/or undergoing PCI

Antithrombotic therapy in patients with atrial fibrillation and acute coronary syndrome and / or undergoing percutaneous coronary intervention

Triple therapy in patients with atrial fibrillation and acute coronary syndrome or percutaneous coronary intervention/stenting

Comparison of early clinical outcomes between dual antiplatelet therapy and triple antithrombotic therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention

Management of Antithrombotic Therapy in Atrial Fibrillation Patients Undergoing PCI